BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 16956919)

  • 21. Drugs for inflammatory bowel disease.
    Treat Guidel Med Lett; 2012 Mar; 10(115):19-28. PubMed ID: 22361569
    [No Abstract]   [Full Text] [Related]  

  • 22. Mucosal T cell proliferation and apoptosis in inflammatory bowel disease.
    Sturm A; de Souza HS; Fiocchi C
    Curr Drug Targets; 2008 May; 9(5):381-7. PubMed ID: 18473766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of T lymphocyte apoptosis by sulphasalazine in patients with Crohn's disease.
    Doering J; Begue B; Lentze MJ; Rieux-Laucat F; Goulet O; Schmitz J; Cerf-Bensussan N; Ruemmele FM
    Gut; 2004 Nov; 53(11):1632-8. PubMed ID: 15479684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution and density of TNF immunoreactivity in chronic inflammatory bowel disease.
    Murch SH; Braegger CP; Walker-Smith JA; MacDonald TT
    Adv Exp Med Biol; 1995; 371B():1327-30. PubMed ID: 7502810
    [No Abstract]   [Full Text] [Related]  

  • 25. New therapies for inflammatory bowel disease: from the bench to the bedside.
    Danese S
    Gut; 2012 Jun; 61(6):918-32. PubMed ID: 22115827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of 6-mercaptopurine and azathioprine with 5-aminosalicylic acid agents.
    Present DH
    Gastroenterology; 2000 Jul; 119(1):276. PubMed ID: 10928833
    [No Abstract]   [Full Text] [Related]  

  • 27. Chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease.
    Bauditz J; Lochs H; Schreiber S
    N Engl J Med; 1998 Jan; 338(5):334. PubMed ID: 9446035
    [No Abstract]   [Full Text] [Related]  

  • 28. [The mucosal immune system. How clear is the pathophysiology?].
    Holtmann M; Mudter J; Galle PR; Neurath MF
    Internist (Berl); 2002 Nov; 43(11):1343-4, 1347-53. PubMed ID: 12524915
    [No Abstract]   [Full Text] [Related]  

  • 29. The immunology of inflammatory bowel disease.
    MacKechnie HL
    Henry Ford Hosp Med J; 1982; 30(1):25-32. PubMed ID: 6123493
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapy of chronic inflammatory bowel diseases].
    Beglinger C
    Ther Umsch; 1997 Nov; 54(11):649-53. PubMed ID: 9454368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treating Crohn's disease by inducing T lymphocyte apoptosis.
    Van Den Brande JM; Peppelenbosch MP; Van Deventer SJ
    Ann N Y Acad Sci; 2002 Nov; 973():166-80. PubMed ID: 12485856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical therapy of IBD in 2009.
    Harris A; Feller ER; Shah SA
    Med Health R I; 2009 Mar; 92(3):78-81. PubMed ID: 19385382
    [No Abstract]   [Full Text] [Related]  

  • 33. [Changing treatment of inflammatory bowel diseases].
    Karvonen AL; Matikainen M; Turunen U
    Duodecim; 1994; 110(20):1945-54. PubMed ID: 7555809
    [No Abstract]   [Full Text] [Related]  

  • 34. [Chronic inflammatory bowel diseases. Update on evidence-based therapy].
    MMW Fortschr Med; 2005 Apr; 147(17):58-9. PubMed ID: 15903063
    [No Abstract]   [Full Text] [Related]  

  • 35. Advances in Pediatric Inflammatory Bowel Disease.
    Maxwell EC; Grossman AB
    Adolesc Med State Art Rev; 2016; 27(1):57-74. PubMed ID: 27363233
    [No Abstract]   [Full Text] [Related]  

  • 36. Interferon alpha-2A (roferon) as a treatment of inflammatory bowel disease in children and adolescents.
    Hadziselimovic F; Schaub U; Emmons LR
    Adv Exp Med Biol; 1995; 371B():1323-6. PubMed ID: 7502809
    [No Abstract]   [Full Text] [Related]  

  • 37. [Postoperative recurrence: adalimumab is an effective standard medication].
    Hofmann-Aßmus M
    Z Gastroenterol; 2014 Mar; 52(3):260. PubMed ID: 24761446
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immune responses in intestinal mucosa].
    Kanai T; Watanabe M
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():459-67. PubMed ID: 15861696
    [No Abstract]   [Full Text] [Related]  

  • 39. Understanding the delayed onset of action of azathioprine in IBD: are we there yet?
    Atreya I; Neurath MF
    Gut; 2009 Mar; 58(3):325-6. PubMed ID: 19211850
    [No Abstract]   [Full Text] [Related]  

  • 40. Case report: combination therapy with granulocyte apheresis and infliximab for refractory Crohn's disease.
    González Carro P; Pérez Roldán F; Roncero García Escribano O; Lafuente R; Legaz Huidobro ML; Amigo Echenagusía A
    J Clin Apher; 2006 Dec; 21(4):249-51. PubMed ID: 16607627
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.